← Eichor
Study identifier: NCT06882057 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

Condition: Acute Lymphoblastic Leukemia ALL · Childhood Leukemia, Acute Lymphoblastic · B Cell Acute Lymphoblastic Leukemia (B-ALL)  ·  Sponsor: Institute of Hematology & Blood Diseases Hospital, China

PhasePhase 2/Phase 3
Planned participants3000
Who can joinAll sexes, 1 Year to 18 Years
Healthy volunteersNo

About this study

CCCG-ALL2025 LR-B-ALL plan is designed based on the CCCG-ALL2020 plan. This is a clinical trial using 14 days of blinatumomab (Blina-14) as early intensification after induction therapy and 2nd Blina-14 in consolidation therapy in all newly diagnosed provisional low-risk (LR) pediatric acute lymphoblastic leukemia (ALL) patients, regardless of measurable residual diseases (MRD) status. We will compare the efficacy of chemotherapy combined with Blina-14, comparing to CAT+ intensification or historical regimens. Patients with early remission in depth will receive chemo-light late intensification and maintenance therapy afterwards. Early complete remission in depth and maintenance reduction will be determined by next-generation sequencing (Ig-NGS MRD).

This description comes directly from the study's public registry record.

Talk to the study team

Xiaofan Zhu, MD  ·  + 86 22 23909001  ·  xfzhu@ihcams.ac.cn

Jingliao Zhang, MD  ·  +86 22 23909196  ·  zhangjingliao@ihcams.ac.cn

Always discuss trial participation with your own doctor first.

Locations (27)

Anhui Medical University Second Affiliated HospitalHefei, Anhui, ChinaNot Yet Recruiting
Anhui Provincial Children's HospitalHefei, Anhui, ChinaNot Yet Recruiting
Chongqing Medical University Affiliated Children's HospitalChongqing, Chongqing Municipality, ChinaNot Yet Recruiting
Fujian Medical University Union HospitalFuzhou, Fujian, ChinaNot Yet Recruiting
Guangzhou Women and Children's Medical CenterGuangzhou, Guangdong, ChinaNot Yet Recruiting
Nanfang Hospital, Southern Medical UniversityGuangzhou, Guangdong, ChinaNot Yet Recruiting
The People's Hospital of Guangxi Zhuang Autonomous RegionNanning, Guangxi, ChinaNot Yet Recruiting
The Affiliated Hospital of Guizhou Medical UniversityGuiyang, Guizhou, ChinaNot Yet Recruiting
Tongji Hospital of Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei, ChinaNot Yet Recruiting
Union Hospital of Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei, ChinaNot Yet Recruiting
Wuhan Children's HospitalWuhan, Hubei, ChinaNot Yet Recruiting
Hunan Children's HospitalChangsha, Hunan, ChinaNot Yet Recruiting

+ 15 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06882057